These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27063992)

  • 1. Circulating Immune Complexes of IgA Bound to Beta 2 Glycoprotein are Strongly Associated with the Occurrence of Acute Thrombotic Events.
    Martínez-Flores JA; Serrano M; Pérez D; Cámara A G; Lora D; Morillas L; Ayala R; Paz-Artal E; Morales JM; Serrano A
    J Atheroscler Thromb; 2016 Oct; 23(10):1242-1253. PubMed ID: 27063992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of circulating immune complexes of human IgA and beta 2 glycoprotein I in patients with antiphospholipid syndrome symptomatology.
    Martínez-Flores JA; Serrano M; Pérez D; Lora D; Paz-Artal E; Morales JM; Serrano A
    J Immunol Methods; 2015 Jul; 422():51-8. PubMed ID: 25865263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β
    Serrano M; Martínez-Flores JA; Pérez D; García F; Cabrera-Marante O; Pleguezuelo D; Paz-Artal E; Morales JM; González E; Serrano A
    Circulation; 2017 May; 135(20):1922-1934. PubMed ID: 28249878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Complexes of Beta-2-Glycoprotein I and IgA Antiphospholipid Antibodies Identify Patients With Elevated Risk of Thrombosis and Early Mortality After Heart Transplantation.
    Serrano M; Morán L; Martinez-Flores JA; Mancebo E; Pleguezuelo D; Cabrera-Marante O; Delgado J; Serrano A
    Front Immunol; 2019; 10():2891. PubMed ID: 31921152
    [No Abstract]   [Full Text] [Related]  

  • 5. Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome.
    Pérez D; Stojanovich L; Naranjo L; Stanisavljevic N; Bogdanovic G; Serrano M; Serrano A
    Front Immunol; 2018; 9():2644. PubMed ID: 30524428
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiphospholipid syndrome and IgA anti-beta2-glycoprotein I antibodies: when Cinderella becomes a princess.
    Pérez D; Tincani A; Serrano M; Shoenfeld Y; Serrano A
    Lupus; 2018 Feb; 27(2):177-178. PubMed ID: 29067871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome.
    Naranjo L; Stojanovich L; Djokovic A; Andreoli L; Tincani A; Maślińska M; Sciascia S; Infantino M; Garcinuño S; Kostyra-Grabczak K; Manfredi M; Regola F; Stanisavljevic N; Milanovic M; Saponjski J; Roccatello D; Cecchi I; Radin M; Benucci M; Pleguezuelo D; Serrano M; Shoenfeld Y; Serrano A
    Front Immunol; 2022; 13():957201. PubMed ID: 36172349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I.
    McDonnell T; Artim-Esen B; Wincup C; Ripoll VM; Isenberg D; Giles IP; Rahman A; Pericleous C
    Front Immunol; 2018; 9():2244. PubMed ID: 30323817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated IgA anti- β2 glycoprotein I antibodies in patients with clinical criteria for antiphospholipid syndrome.
    Ruiz-García R; Serrano M; Martínez-Flores JÁ; Mora S; Morillas L; Martín-Mola MÁ; Morales JM; Paz-Artal E; Serrano A
    J Immunol Res; 2014; 2014():704395. PubMed ID: 24741618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A; Kickler TS; Petri M
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
    Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
    Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of circulating immune complexes and antiphospholipid antibodies (anti beta 2 glycoprotein 1) in heroin addicts and their clinical significance.
    Simonovska N; Chibishev A; Bozinovska C; Grcevska L; Dimitrovski K; Neceva V
    Med Arh; 2011; 65(6):324-6. PubMed ID: 22299289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke.
    Naranjo L; Ostos F; Gil-Etayo FJ; Hernández-Gallego J; Cabrera-Marante Ó; Pleguezuelo DE; Díaz-Simón R; Cerro M; Lora D; Martínez-Salio A; Serrano A
    Front Cardiovasc Med; 2021; 8():665741. PubMed ID: 34012984
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus.
    Tebo AE; Willis R; Jaskowski TD; Guerra M; Pierangeli SS; Salmon J; Petri M; Branch DW
    Clin Chim Acta; 2016 Sep; 460():107-13. PubMed ID: 27346478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Presence of Pretransplant Antiphospholipid Antibodies IgA Anti-β-2-Glycoprotein I as a Predictor of Graft Thrombosis After Renal Transplantation.
    Morales JM; Serrano M; Martínez-Flores JA; Pérez D; Castro MJ; Sánchez E; García F; Rodríguez-Antolín A; Alonso M; Gutierrez E; Morales E; Praga M; González E; Andrés A; Paz-Artal E; Martínez MA; Serrano A
    Transplantation; 2017 Mar; 101(3):597-607. PubMed ID: 27140515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome.
    Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F
    Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
    Lee SS; Cho ML; Joo YS; Kim WU; Hong YS; Min JK; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.